Lv1
94 积分 2026-07-27 加入
HBx-induced HSPB1 is a potential therapeutic target owing to its modulation of HBV cccDNA and hepatic immune responses
43分钟前
待确认
Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B Infection
5天前
已完结
Explainability and artificial intelligence in medicine
12天前
已完结
Nucleos(t)ide withdrawal versus nucleos(t)ide withdrawal with adjuvant pegylated-interferon in HBeAg-negative hepatitis B virus infection (NUC-B trial)
19天前
已完结
Phase 2 Safety and efficacy of oral TLR8 agonist selgantolimod (GS-9688) for 24 weeks in virally-suppressed adult patients with chronic hepatitis B
1个月前
已完结
Safety and Pharmacodynamics of Oral TLR-7 agonist GS-9620 in patients with Chronic Hepatitis B
1个月前
已完结
Safety, pharmacokinetics and pharmacodynamics of oral TLR8 agonist GS-9688 in patients with chronic hepatitis B: a randomized, placebo-controlled, double-blind phase 1b study
1个月前
已关闭
皖公网安备34019202002308
